{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:49:32Z","timestamp":1762505372813},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,7,3]],"date-time":"2008-07-03T00:00:00Z","timestamp":1215043200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00213-008-1229-1","type":"journal-article","created":{"date-parts":[[2008,7,2]],"date-time":"2008-07-02T09:45:49Z","timestamp":1214991949000},"page":"157-165","source":"Crossref","is-referenced-by-count":21,"title":["Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia"],"prefix":"10.1007","volume":"200","author":[{"given":"Davide","family":"Amato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Stasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Borsini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Nencini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,3]]},"reference":[{"key":"1229_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2006.03.038","volume":"172","author":"D Amato","year":"2006","unstructured":"Amato D, Milella MS, Badiani A, Nencini P (2006) Compulsive-like effects of repeated administration of quinpirole on drinking behavior in rats. Behav Brain Res 172:1\u201313","journal-title":"Behav Brain Res"},{"key":"1229_CR2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbr.2006.11.016","volume":"177","author":"D Amato","year":"2007","unstructured":"Amato D, Milella MS, Badiani A, Nencini P (2007) Compulsive-like effects of quinpirole on drinking behavior in rats are inhibited by substituting ethanol for water. Behav Brain Res 177:340\u2013346","journal-title":"Behav Brain Res"},{"key":"1229_CR3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3940(02)00261-6","volume":"325","author":"A Badiani","year":"2002","unstructured":"Badiani A, Vaccaro R, Burdino R, Casini A, Valeri P, Renda TG, Nencini P (2002) Dissociation in the effects of the D2\/D3 dopaminergic agonist quinpirole on drinking and on vasopressin levels in the rat. Neurosci Lett 325:79\u201382","journal-title":"Neurosci Lett"},{"key":"1229_CR4","first-page":"CD003544","volume":"4","author":"G Brookes","year":"2006","unstructured":"Brookes G, Ahmed AG (2006) Pharmacological treatments for psychosis-related polydipsia. Cochrane Database Syst Rev(4):CD003544","journal-title":"Cochrane Database Syst Rev"},{"key":"1229_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0091-3057(86)90223-6","volume":"25","author":"GD Carr","year":"1986","unstructured":"Carr GD, White NM (1986) Contributions of dopamine terminal areas to amphetamine-induced anorexia and adipsia. Pharmacol Biochem Behav 25:17\u201322","journal-title":"Pharmacol Biochem Behav"},{"key":"1229_CR6","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/0024-3205(88)90343-8","volume":"42","author":"E Castaneda","year":"1988","unstructured":"Castaneda E, Becker JB, Robinson TE (1988) The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro. Life Sci 42:2447\u20132456","journal-title":"Life Sci"},{"key":"1229_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0920-9964(91)90050-2","volume":"5","author":"G Chouinard","year":"1991","unstructured":"Chouinard G (1991) Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment. Schizophr Res 5:21\u201333","journal-title":"Schizophr Res"},{"key":"1229_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(99)00155-2","volume":"109","author":"I Cioli","year":"2000","unstructured":"Cioli I, Caricati A, Nencini P (2000) Quinpirole- and amphetamine-induced hyperdipsia: influence of fluid palatability and behavioral cost. Behav Brain Res 109:9\u201318","journal-title":"Behav Brain Res"},{"key":"1229_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0920-9964(01)00292-4","volume":"57","author":"J Leon De","year":"2002","unstructured":"De Leon J, Tracy J, McCann E, McGrory A (2002) Polydipsia and schizophrenia in a psychiatric hospital: a replication study. Schizophr Res 57:293\u2013301","journal-title":"Schizophr Res"},{"key":"1229_CR10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4088\/JCP.v67n0411","volume":"67","author":"B Dell\u2019Osso","year":"2006","unstructured":"Dell\u2019Osso B, Nestadt G, Allen A, Hollander E (2006) Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive\u2013compulsive disorder: a critical review. J Clin Psychiatry 67:600\u2013610","journal-title":"J Clin Psychiatry"},{"key":"1229_CR11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00008877-199310000-00007","volume":"4","author":"M Didriksen","year":"1993","unstructured":"Didriksen M, Christensen AV (1993) The attenuation of schedule-induced polydipsia by dopamine blockers is not an expression of extrapyramidal side effect liability. Behav Pharmacol 4:517\u2013522","journal-title":"Behav Pharmacol"},{"key":"1229_CR12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF02245706","volume":"113","author":"M Didriksen","year":"1993","unstructured":"Didriksen M, Olsen GM, Christensen AV (1993) Effect of clozapine upon schedule-induced polydipsia (SIP) resembles neither the actions of dopamine D1 nor D2 blockade. Psychopharmacology (Berl) 113:250\u2013256","journal-title":"Psychopharmacology (Berl)"},{"key":"1229_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S109285290001004X","volume":"10","author":"D Eilam","year":"2005","unstructured":"Eilam D, Szechtman H (2005) Psychostimulant-induced behavior as an animal model of obsessive\u2013compulsive disorder: an ethological approach to the form of compulsive rituals. CNS Spectr 10:191\u2013192","journal-title":"CNS Spectr"},{"key":"1229_CR14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1901\/jeab.1967.10-199","volume":"10","author":"JL Falk","year":"1967","unstructured":"Falk JL (1967) Control of schedule-induced polydipsia: type, size, and spacing of meals. J Exp Anal Behav 10:199\u2013206","journal-title":"J Exp Anal Behav"},{"key":"1229_CR15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00213-005-0131-3","volume":"182","author":"MJ Fell","year":"2005","unstructured":"Fell MJ, Neill JC, Rao C, Marshall KM (2005) Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats. Psychopharmacology (Berl) 182:499\u2013507","journal-title":"Psychopharmacology (Berl)"},{"key":"1229_CR16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF00432117","volume":"80","author":"RW Foltin","year":"1983","unstructured":"Foltin RW, Woolverton WL, Schuster CR (1983) The effect of d-amphetamine and haloperidol alone and in combination on milk drinking in rats. Psychopharmacology 80:342\u2013344","journal-title":"Psychopharmacology"},{"key":"1229_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-4328(97)00063-6","volume":"89","author":"S Fraioli","year":"1997","unstructured":"Fraioli S, Cioli I, Nencini P (1997) Amphetamine reinstates polydipsia induced by chronic exposure to quinpirole, a dopaminergic D2 agonist, in rats. Behav Brain Res 89:199\u2013215","journal-title":"Behav Brain Res"},{"key":"1229_CR18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2165\/00003088-198917060-00004","volume":"17","author":"JS Froemming","year":"1989","unstructured":"Froemming JS, Lam YW, Jann MW, Davis CM (1989) Pharmacokinetics of haloperidol. Clin Pharmacokinet 17:396\u2013423","journal-title":"Clin Pharmacokinet"},{"key":"1229_CR19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/oxfordjournals.schbul.a007086","volume":"30","author":"MB Goldman","year":"2004","unstructured":"Goldman MB, Mitchell CP (2004) What is the functional significance of hippocampal pathology in schizophrenia? Schizophr Bull 30:367\u2013392","journal-title":"Schizophr Bull"},{"key":"1229_CR20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJM198802183180702","volume":"318","author":"MB Goldman","year":"1988","unstructured":"Goldman MB, Luchins DJ, Robertson GL (1988) Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med 318:397\u2013403","journal-title":"N Engl J Med"},{"key":"1229_CR21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archpsyc.1997.01830170069010","volume":"54","author":"MB Goldman","year":"1997","unstructured":"Goldman MB, Robertson GL, Luchins DJ, Hedeker D, Pandey GN (1997) Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry 54:443\u2013449","journal-title":"Arch Gen Psychiatry"},{"key":"1229_CR22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hipo.20292","volume":"17","author":"MB Goldman","year":"2007","unstructured":"Goldman MB, Torres IJ, Keedy S, Marlow-O\u2019Connor M, Beenken B, Pilla R (2007a) Reduced anterior hippocampal formation volume in hyponatremic schizophrenic patients. Hippocampus 17:554\u2013562","journal-title":"Hippocampus"},{"key":"1229_CR23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1210\/jc.2006-1131","volume":"92","author":"MB Goldman","year":"2007","unstructured":"Goldman MB, Wood G, Goldman MB, Gavin M, Paul S, Zaheer S, Fayyaz G, Pilla RS (2007b) Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients. J Clin Endocrinol Metab 92:698\u2013704","journal-title":"J Clin Endocrinol Metab"},{"key":"1229_CR24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0091-3057(91)90308-O","volume":"38","author":"MS Hooks","year":"1991","unstructured":"Hooks MS, Jones GH, Smith AD, Neill DB, Justice JB Jr. (1991) Individual differences in locomotor activity and sensitization. Pharmacol Biochem Behav 38:467\u2013470","journal-title":"Pharmacol Biochem Behav"},{"key":"1229_CR25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0006-8993(94)90973-3","volume":"657","author":"C Jodogne","year":"1994","unstructured":"Jodogne C, Marinelli M, Le Moal M, Piazza PV (1994) Animals predisposed to develop amphetamine self-administration show higher susceptibility to develop contextual conditioning of both amphetamine-induced hyperlocomotion and sensitization. Brain Res 657:236\u2013244","journal-title":"Brain Res"},{"key":"1229_CR26","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/ajp.155.7.921","volume":"155","author":"S Kapur","year":"1998","unstructured":"Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S (1998) 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry 155:921\u2013928","journal-title":"Am J Psychiatry"},{"key":"1229_CR27","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK (2005) Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209\u20131223","journal-title":"N Engl J Med"},{"key":"1229_CR28","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuropharm.2006.07.006","volume":"51","author":"EJ Lin","year":"2006","unstructured":"Lin EJ, Lee NJ, Slack K, Karl T, Duffy L, O\u2019brien E, Matsumoto I, Dedova I, Herzog H, Sainsbury A (2006) Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats. Neuropharmacology 51:1129\u20131136","journal-title":"Neuropharmacology"},{"key":"1229_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01578748","volume":"76","author":"T Ljungberg","year":"1989","unstructured":"Ljungberg T (1989) Dopamine D-2 antagonists reverse apomorphine-induced decreased water intake in the rat: prediction of antipsychotic drugs with few extrapyramidal side-effects? J Neural Transm 76:79\u201390","journal-title":"J Neural Transm"},{"key":"1229_CR30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S1461145704004900","volume":"28","author":"C Matsumoto","year":"2005","unstructured":"Matsumoto C, Shinkai T, De Luca V, Hwang R, Hori H, Lanktree M, Ohmori O, Kennedy JL, Nakamura J (2005) Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia. Int J Neuropsychopharmacol 28:245\u2013253","journal-title":"Int J Neuropsychopharmacol"},{"key":"1229_CR31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.physbeh.2004.04.055","volume":"81","author":"MJ McKinley","year":"2004","unstructured":"McKinley MJ, Cairns MJ, Denton DA, Egan G, Mathai ML, Uschakov A, Wade JD, Weisinger RS, Oldfield BJ (2004) Physiological and pathophysiological influences on thirst. Physiol Behav 81:795\u2013803","journal-title":"Physiol Behav"},{"key":"1229_CR32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00002826-200107000-00002","volume":"24","author":"J Micallef","year":"2001","unstructured":"Micallef J, Blin O (2001) Neurobiology and clinical pharmacology of obsessive\u2013compulsive disorder. Clin Neuropharmacol 24:191\u2013207","journal-title":"Clin Neuropharmacol"},{"key":"1229_CR33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-007-1044-0","volume":"197","author":"MS Milella","year":"2008","unstructured":"Milella MS, Amato D, Badiani A, Nencini P (2008) The influence of cost manipulation on water contrafreeloading induced by repeated exposure to quinpirole in the rat. Psychopharmacology 197:379\u2013390 doi: 10.1007\/s00213-007-1044-0","journal-title":"Psychopharmacology"},{"key":"1229_CR34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0006-8993(85)90366-X","volume":"348","author":"G Mittleman","year":"1985","unstructured":"Mittleman G, Valenstein ES (1985) Individual differences in non-regulatory ingestive behavior and catecholamine systems. Brain Res 348:112\u2013117","journal-title":"Brain Res"},{"key":"1229_CR35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0031-9384(86)90311-2","volume":"36","author":"G Mittleman","year":"1986","unstructured":"Mittleman G, Valenstein ES (1986) Unilateral substantia nigra lesions and schedule-induced polydipsia. Physiol Behav 36:437\u2013440","journal-title":"Physiol Behav"},{"key":"1229_CR36","first-page":"638","volume":"271","author":"G Mittleman","year":"1994","unstructured":"Mittleman G, Rosner AL, Schaub CL (1994) Polydispia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists. J Pharmacol Exp Ther 271:638\u2013650","journal-title":"J Pharmacol Exp Ther"},{"key":"1229_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","volume":"10","author":"S Miyamoto","year":"2005","unstructured":"Miyamoto S, Duncan GE, Marx CE, Lieberman JA (2005) Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10:79\u2013104","journal-title":"Mol Psychiatry"},{"key":"1229_CR38","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0091-3057(88)90095-0","volume":"30","author":"P Nencini","year":"1988","unstructured":"Nencini P (1988) The role of opiate mechanisms in the development of tolerance to the anorectic effects of amphetamines. Pharmacol Biochem Behav 30:755\u2013764","journal-title":"Pharmacol Biochem Behav"},{"key":"1229_CR39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-3057(94)90019-1","volume":"47","author":"P Nencini","year":"1994","unstructured":"Nencini P, Fraioli S (1994) Environment-specific reinstatement of amphetamine-mediated hyperdipsia by morphine and (\u2212)-norpseudoephedrine. Pharmacol Biochem Behav 47:339\u2013343","journal-title":"Pharmacol Biochem Behav"},{"key":"1229_CR40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0091-3057(94)90499-5","volume":"48","author":"P Nencini","year":"1994","unstructured":"Nencini P, Valeri P (1994) The role of opioid mechanisms in the anorectic effects of stimulants: U50,488H enhances amphetamine inhibition of free feeding in rats. Pharmacol Biochem Behav 48:63\u201368","journal-title":"Pharmacol Biochem Behav"},{"key":"1229_CR41","first-page":"147","volume":"245","author":"P Nencini","year":"1988","unstructured":"Nencini P, Johanson CE, Schuster CR (1988) Sensitization to kappa opioid mechanisms associated with tolerance to the anorectic effects of cathinone. J Pharmacol Exp Ther 245:147\u2013154","journal-title":"J Pharmacol Exp Ther"},{"key":"1229_CR42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0361-9230(90)90055-5","volume":"25","author":"P Nencini","year":"1990","unstructured":"Nencini P, Valeri P, Morrone LA (1990) Dapiprazole, a selective alpha-1 adrenoceptor antagonist, inhibits diuresis but not polydipsia produced by amphetamine in rats. Brain Res Bull 25:765\u2013767","journal-title":"Brain Res Bull"},{"key":"1229_CR43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","volume":"396","author":"TE Robinson","year":"1986","unstructured":"Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157\u2013198","journal-title":"Brain Res"},{"key":"1229_CR44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0195-6663(81)80036-0","volume":"2","author":"N Rowland","year":"1981","unstructured":"Rowland N, Antelman SM, Kocan D (1981) Elevated water intake in rats treated chronically with amphetamine: drinking in excess of need? Appetite 2:51\u201366","journal-title":"Appetite"},{"issue":"27","key":"1229_CR45","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1523\/JNEUROSCI.5416-06.2007","volume":"14","author":"AN Samaha","year":"2007","unstructured":"Samaha AN, Seeman P, Stewart J, Rajabi H, Kapur S (2007) \u201cBreakthrough\u201d dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time. J Neurosci 14(27):2979\u20132986","journal-title":"J Neurosci"},{"key":"1229_CR46","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1073\/pnas.0409766102","volume":"102","author":"P Seeman","year":"2005","unstructured":"Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardway SK, Grandy DK, Premont RT, Sotnikova TD, Boksa P, El-Ghundi M, O\u2019dowd BF, George SR, Perreault ML, Mannisto PT, Robinson S, Palmiter RD, Tallerico T (2005) Dopamine supersensitivity correlates with D2 high states, implying many paths to psychosis. Proc Natl Acad Sci U S A 102:3513\u20133518","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1229_CR47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-9964(96)00039-4","volume":"21","author":"MS Shutty Jr","year":"1996","unstructured":"Shutty MS Jr (1996) Cigarette use, drinking and voiding in schizophrenic patients with polydipsia and hyponatremia. Schizophr Res 21:195\u2013197","journal-title":"Schizophr Res"},{"key":"1229_CR48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0005-7916(95)00049-6","volume":"26","author":"MS Shutty Jr","year":"1995","unstructured":"Shutty MS Jr, McCulley K, Pigott B (1995) Association between stereotypic behavior and polydipsia in chronic schizophrenic patients. J Behav Ther Exp Psychiatry 26:339\u2013343","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"1229_CR49","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0091-3057(89)90064-6","volume":"32","author":"SH Snodgrass","year":"1989","unstructured":"Snodgrass SH, Allen JD (1989) Time-response effects of pimozide on operant behavior and schedule-induced polydipsia. Pharmacol Biochem Behav 32:949\u2013955","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl. 1","key":"1229_CR50","first-page":"S142","volume":"9","author":"MA Stasi","year":"2006","unstructured":"Stasi MA, Di Serio S, Vertechy M, Minetti P, Ghirardi O, Borsini F, Carminati P (2006) ST2472 (9-piperazin-1-yl-pyrrole[2,1-B][1-3]benzothiazepin): a novel safe potential antipsychotic. XXVth CINP Biennal Congress. Chicago (USA), July 9\u201313. Int J Neuropsychopharmacol 9(Suppl. 1):S142\u2013S143","journal-title":"Int J Neuropsychopharmacol"},{"key":"1229_CR51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S146114570700805X","volume":"11","author":"MA Stasi","year":"2008","unstructured":"Stasi MA, Di Serio S, Vertechy M, Schiamone A, Ghirardi O, Minetti P, Campiani G, Borsini F, P Carminati P (2008) ST2472: a new potential antipsychotic with very low liability to induce side effects. Int. J Neuropsychopharmacol 11:309\u2013319","journal-title":"Int. J Neuropsychopharmacol"},{"key":"1229_CR52","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/0024-3205(90)90311-E","volume":"47","author":"T Suhara","year":"1990","unstructured":"Suhara T, Inoue O, Kobayasi K (1990) Effect of desipramine on dopamine receptor binding in vivo. Life Sci 47:2119\u20132126","journal-title":"Life Sci"},{"key":"1229_CR53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0091-3057(78)90066-7","volume":"8","author":"IP Stolerman","year":"1978","unstructured":"Stolerman IP, D\u2019Mello GD (1978) Amphetamine-induced hypodypsia and its implications for conditioned taste aversion in rats. Pharmacol Biochem Behav 8:333\u2013338","journal-title":"Pharmacol Biochem Behav"},{"key":"1229_CR54","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1037\/0735-7044.112.6.1475","volume":"112","author":"H Szechtman","year":"1998","unstructured":"Szechtman H, Sulis W, Eilam D (1998) Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive\u2013compulsive disorder (OCD). Behav Neurosci 112:1475\u20131485","journal-title":"Behav Neurosci"},{"key":"1229_CR55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1037\/0033-295X.111.1.111","volume":"111","author":"H Szechtman","year":"2004","unstructured":"Szechtman H, Woody E (2004) Obsessive\u2013compulsive disorder as disturbance of security motivation. Psychol Rev 111:111\u2013127","journal-title":"Psychol Rev"},{"key":"1229_CR56","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0278-5846(98)00033-5","volume":"22","author":"FI Tarazi","year":"1998","unstructured":"Tarazi FI, Yeghiayan SK, Neumeyer JL, Baldessarini RJ (1998) Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: common targets for typical and atypical antipsychotic drugs. Prog Neuropsychopharmacol Biol Psychiatry 22:693\u2013707","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1229_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-4328(85)90012-9","volume":"15","author":"K Taghzouti","year":"1985","unstructured":"Taghzouti K, Simon H, Tazi A, Dantzer R, Le Moal M (1985) The effect of 6-OHDA lesions of the lateral septum on schedule-induced polydipsia. Behav Brain Res 15:1\u20138","journal-title":"Behav Brain Res"},{"key":"1229_CR58","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0091-3057(92)90130-8","volume":"42","author":"KG Todd","year":"1992","unstructured":"Todd KG, Beck CH, Martin-Iverson MT (1992) Effects of D1 and D2 dopamine antagonists on behavior of polydipsic rats. Pharmacol Biochem Behav 42:381\u2013388","journal-title":"Pharmacol Biochem Behav"},{"key":"1229_CR59","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.lfs.2007.01.038","volume":"80","author":"S Uchida","year":"2007","unstructured":"Uchida S, Kato Y, Hirano K, Kagawa Y, Yamada S (2007) Brain neurotransmitter receptor-binding characteristics in rats after oral administration of haloperidol, risperidone and olanzapine. Life Sci 80:1635\u20131640","journal-title":"Life Sci"},{"key":"1229_CR60","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.pbb.2004.04.009","volume":"78","author":"RE Ulloa","year":"2004","unstructured":"Ulloa RE, Nicolini H, Fern\u00e1ndez-Guasti A (2004) Age differences in an animal model of obsessive\u2013compulsive disorder: participation of dopamine: dopamine in an animal model of OCD. Pharmacol Biochem Behav 78:661\u2013666","journal-title":"Pharmacol Biochem Behav"},{"key":"1229_CR61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/npp.1993.54","volume":"9","author":"C Verghese","year":"1993","unstructured":"Verghese C, De Leon J, Simpson GM (1993) Neuroendocrine factors influencing polydipsia in psychiatric patients: an hypothesis. Neuropsychopharmacology 9:157\u2013166","journal-title":"Neuropsychopharmacology"},{"key":"1229_CR62","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0163-1047(82)91292-4","volume":"35","author":"PJ Wellman","year":"1982","unstructured":"Wellman PJ, Clark DE, Rogers JK, Thomas JC (1982) Amphetamine actions in dorsolateral tegmental rats: hypodipsia, anorexia, and central nervous system permeation to [14C] amphetamine. Behav Neural Biol 35:64\u201369","journal-title":"Behav Neural Biol"},{"key":"1229_CR63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02244910","volume":"112","author":"A Woods","year":"1993","unstructured":"Woods A, Smith C, Szewczak M, Dunn RW, Cornfeldt M, Corbett R (1993) Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. Psychopharmacology (Berl) 112:195\u2013198","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1229-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1229-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1229-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:06:42Z","timestamp":1558642002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1229-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,3]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["1229"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1229-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,3]]}}}